Arcturus Therapeutics Holdings Inc.

ARCT Stock Healthcare Biotechnology
$15.19
-0.98 (-6.06%)
Price as of Aug 28, 2026 market close

Performance

1 Month
+156.6%
3 Months
+91.8%
YTD
+147.8%
1 Year
-12.1%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
90.7%
Largest decline max drawdown, since Aug 2025
-76.1%
Risk-adjusted return Sharpe ratio, 1-year
0.37

Own ARCT?

See how ARCT contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.